A Novel Histone Deacetylase Inhibitor Exhibits Antitumor Activity via Apoptosis Induction, F-Actin Disruption and Gene Acetylation in Lung Cancer

BACKGROUND: Lung cancer is the leading cause of cancer mortality worldwide, yet the therapeutic strategy for advanced non-small cell lung cancer (NSCLC) is limitedly effective. In addition, validated histone deacetylase (HDAC) inhibitors for the treatment of solid tumors remain to be developed. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yen-An, Wen, Wei-Ling, Chang, Jer-Wei, Wei, Tzi-Tang, Tan, Yi-Hung Carol, Salunke, Santosh, Chen, Chien-Tien, Chen, Ching-Shih, Wang, Yi-Ching
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939045/
https://www.ncbi.nlm.nih.gov/pubmed/20856855
http://dx.doi.org/10.1371/journal.pone.0012417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939045/
https://www.ncbi.nlm.nih.gov/pubmed/20856855
http://dx.doi.org/10.1371/journal.pone.0012417

Ejemplares similares